GUDID 04713025224011

HSG catheters may be used to evaluate the causes of abnormal uterine bleeding, menstrual disorders, recurrent pregnancy loss or unexplained infertilit

PANPAC MEDICAL CORPORATION

Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter Hysterosonography/endometrial biopsy catheter
Primary Device ID04713025224011
NIH Device Record Keyb51f9099-f376-4337-98f3-fff51d56ff38
Commercial Distribution StatusIn Commercial Distribution
Version Model NumberBA05F-S
Company DUNS657528899
Company NamePANPAC MEDICAL CORPORATION
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datetrue
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS104713025224004 [Primary]
GS104713025224011 [Package]
Contains: 04713025224004
Package: BOX [10 Units]
In Commercial Distribution

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

LKFCannula, Manipulator/Injector, Uterine

Sterilization

Steralize Prior To Usetrue
Device Is Steriletrue

[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


[04713025224011]

Ethylene Oxide


Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2018-08-09
Device Publish Date2018-07-09

Devices Manufactured by PANPAC MEDICAL CORPORATION

04713025222093 - NA2020-05-14 Gellhorn pessary is used to relieve the symptoms of cystocele or rectocele and second or third-degree uterine prolapse.
04713025222109 - NA2020-05-14 Gellhorn pessary is used to relieve the symptoms of cystocele or rectocele and second or third-degree uterine prolapse.
04713025222116 - NA2020-05-14 Gellhorn pessary is used to relieve the symptoms of cystocele or rectocele and second or third-degree uterine prolapse.
04713025222123 - NA2020-05-14 Gellhorn pessary is used to relieve the symptoms of cystocele or rectocele and second or third-degree uterine prolapse.
04713025222130 - NA2020-05-14 Gellhorn pessary is used to relieve the symptoms of cystocele or rectocele and second or third-degree uterine prolapse.
04713025222147 - NA2020-05-14 Gellhorn pessary is used to relieve the symptoms of cystocele or rectocele and second or third-degree uterine prolapse.
04713025222154 - NA2020-05-14 Gellhorn pessary is used to relieve the symptoms of cystocele or rectocele and second or third-degree uterine prolapse.
04713025222161 - NA2020-05-14 Gellhorn pessary is used to relieve the symptoms of cystocele or rectocele and second or third-degree uterine prolapse.

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.